000 | 01499 a2200385 4500 | ||
---|---|---|---|
005 | 20250514061833.0 | ||
264 | 0 | _c20030421 | |
008 | 200304s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.0634912100 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRoca, Ramon | |
245 | 0 | 0 |
_aLoss of p16INK4a results in increased glucocorticoid receptor activity during fibrosarcoma development. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cMar 2003 |
||
300 |
_a3113-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p16 _xdeficiency |
650 | 0 | 4 | _aDNA Methylation |
650 | 0 | 4 |
_aDNA, Neoplasm _xchemistry |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 |
_aFibrosarcoma _xetiology |
650 | 0 | 4 | _aGenes, p16 |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPrecancerous Conditions _xetiology |
650 | 0 | 4 |
_aReceptors, Glucocorticoid _xgenetics |
650 | 0 | 4 | _aTranscriptional Activation |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aKypta, Robert M | |
700 | 1 | _aVivanco, Maria d M | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 100 _gno. 6 _gp. 3113-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.0634912100 _zAvailable from publisher's website |
999 |
_c12419572 _d12419572 |